Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
Summary
This condition encompasses three scenarios related to cardiac-stimulant glycosides and similar drugs: poisoning (overdose), adverse effects from therapeutic use, and underdosing. Cardiac-stimulant glycosides, such as digoxin, are used to treat heart conditions like atrial fibrillation and heart failure. The diagnosis depends on the clinical context—whether the issue stems from excessive intake, unintended reactions to standard doses, or insufficient dosing.
Causes
Poisoning may result from accidental or intentional overdose of cardiac glycosides. Adverse effects occur when the body reacts negatively to therapeutic doses, often due to drug interactions, renal impairment, or individual sensitivity. Underdosing happens when patients take less than prescribed, leading to inadequate treatment of underlying heart conditions.
Risk Factors
- Advanced age, as metabolism and kidney function decline.
- Renal impairment, reducing drug clearance.
- Concurrent use of medications that interact with cardiac glycosides (e.g., diuretics, certain antibiotics).
- History of heart failure or arrhythmias, increasing reliance on these drugs.
- Poor medication adherence or misunderstanding of dosing instructions.
Symptoms
- Nausea, vomiting, and loss of appetite.
- Visual disturbances (e.g., blurred vision, yellow-green halos around lights).
- Arrhythmias (abnormal heart rhythms), including bradycardia or tachycardia.
- Fatigue, dizziness, or confusion.
- In severe cases: seizures, coma, or cardiac arrest.
Diagnosis
Diagnosis involves a detailed patient history (including medication use and symptoms), physical examination, and laboratory tests. Key assessments include measuring serum drug levels (e.g., digoxin levels), electrolyte panels (especially potassium), and cardiac monitoring (e.g., ECG) to detect arrhythmias. Imaging or other tests may rule out alternative causes.
Treatment Options
- For poisoning: Activated charcoal (if recent ingestion), antidotes (e.g., digoxin-specific Fab fragments), and supportive care (e.g., managing arrhythmias or electrolyte imbalances).
- For adverse effects: Discontinuing the drug, adjusting doses, or switching to alternative therapies.
- For underdosing: Reassessing dosing regimens, addressing adherence barriers, and optimizing therapy for the underlying condition.
Prognosis and Follow-Up
Prognosis varies by scenario. Poisoning outcomes depend on the dose and timely intervention; severe cases may be life-threatening. Adverse effects often resolve with dose adjustments or discontinuation. Underdosing may lead to worsening heart failure if unaddressed. Follow-up includes monitoring drug levels, cardiac function, and symptom resolution.
Complications
- Severe arrhythmias (e.g., ventricular tachycardia) or heart block.
- Electrolyte imbalances (e.g., hypokalemia or hyperkalemia).
- Kidney injury or failure.
- Neurological damage (e.g., seizures, coma) in severe poisoning.
Lifestyle & Prevention
- Educate patients on proper dosing and signs of toxicity (e.g., visual changes, nausea).
- Regularly review medication lists to avoid interactions.
- Monitor renal function and electrolytes in high-risk patients.
- Use pill organizers or reminders to improve adherence.
When to Seek Professional Help
Seek immediate care for symptoms like severe nausea, visual disturbances, fainting, or irregular heartbeat. Prompt evaluation is critical for suspected poisoning or adverse effects to prevent complications.
Tips for Medical Coders
Document the clinical context clearly (e.g., poisoning, adverse effect, or underdosing) to assign the correct code. Specify whether the encounter is initial, subsequent, or sequela. Include details on drug levels, symptoms, and interventions to support coding accuracy. Note that T46.0 covers all three scenarios, so clinical documentation must clarify the specific situation.
T46.0 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.